AUROPHARMA

Sector: Pharmaceuticals Market cap: ₹66,000+ crore (large-cap pharma) Stock has been consolidating near resistance zone ₹1,200–₹1,250. A breakout above ₹1,250 with volume could push price towards: ₹1,349 ₹1,420 ₹1,531 (medium-term target) Recent business trends: Revenue growth driven by US and Europe formulations business. Europe sales growing 18% YoY. Q4 FY25 profit about ₹903 crore, slightly lower YoY but stable overall. Growth drivers Biosimilars and injectables pipeline Expansion in Europe and biologics manufacturing Contract manufacturing with global pharma partners